| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-07 |